France· FR:69166985
EYLEA 114,3 mg/mL, solution injectable
A medicinal product containing aflibercept, registered in France by BAYER AG (ALLEMAGNE), on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- AFLIBERCEPT
- Manufacturer
- BAYER AG (ALLEMAGNE)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip1334009302833251 flacon en verre de 0,263 ml + 1 aiguille à filtreEUR 392.56
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Aflibercept in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwedenEylea 114,3 mg/ml Injektionsvätska, lösningBayer AG
- CzechiaEYLEABayer AG, Leverkusen
- SpainEYLEA 114,3 MG/ML SOLUCION INYECTABLEBayer Ag
- IrelandEylea 114.3 mg/ml solution for injectionBayer AG
- IcelandEyleaBayer AG*
- BelgiumEylea 114.3 mg/mlBayer
- NetherlandsEylea 114,3 mg/ml oplossing voor injectieBayer AG
- NorwayEyleaBayer AG
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- United Kingdom (Northern Ireland) · Vgenfli
- Iceland · Afiveg, Afqlir
- Liechtenstein · Afiveg, Afqlir
- Norway · Afiveg, Afqlir
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e1f914a4-b1f3-4c4f-934c-3c33532bce3d GET /v1/drugs/e1f914a4-b1f3-4c4f-934c-3c33532bce3d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "69166985",
"date_amm": "2024-01-05",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/12/797",
"substance": "AFLIBERCEPT",
"statut_amm": "Autorisation active",
"statut_bdm": "Warning disponibilité",
"forme_pharmaceutique": "solution injectable",
"voies_administration": "intravitréenne",
"etat_commercialisation": "Non commercialisée",
"surveillance_renforcee": "Non"
}See everything about aflibercept.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.